Literature DB >> 20869460

Molecular mechanisms involved in the early steps of flavivirus cell entry.

Bärbel Kaufmann1, Michael G Rossmann.   

Abstract

Flaviviruses enter their host cells by receptor-mediated endocytosis, a well-orchestrated process of receptor recognition, penetration and uncoating. Recent findings on these early steps in the life cycle of flaviviruses are the focus of this review.
Copyright © 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 20869460      PMCID： PMC3014442          DOI： 10.1016/j.micinf.2010.09.005

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  95 in total

Review 1.  A structural perspective of the flavivirus life cycle.

Authors:  Suchetana Mukhopadhyay; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

2.  Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

Authors:  J J H Chu; R Rajamanonmani; J Li; R Bhuvanakantham; J Lescar; M-L Ng
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

3.  Rab 5 is required for the cellular entry of dengue and West Nile viruses.

Authors:  Manoj N Krishnan; Bindu Sukumaran; Utpal Pal; Herve Agaisse; James L Murray; Thomas W Hodge; Erol Fikrig
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells.

Authors:  Jorge Reyes-Del Valle; Salvador Chávez-Salinas; Fernando Medina; Rosa M Del Angel
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Dengue virus infection of human T lymphocytes.

Authors:  N A Mentor; I Kurane
Journal:  Acta Virol       Date:  1997-06       Impact factor: 1.162

6.  Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals.

Authors:  Pierre-Yves Lozach; Laura Burleigh; Isabelle Staropoli; Erika Navarro-Sanchez; Julie Harriague; Jean-Louis Virelizier; Felix A Rey; Philippe Desprès; Fernando Arenzana-Seisdedos; Ali Amara
Journal:  J Biol Chem       Date:  2005-04-26       Impact factor: 5.157

7.  N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity.

Authors:  Sheri L Hanna; Theodore C Pierson; Melissa D Sanchez; Asim A Ahmed; Mariam M Murtadha; Robert W Doms
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

8.  Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70.

Authors:  Arturo Cabrera-Hernandez; Chutima Thepparit; Lukkana Suksanpaisan; Duncan R Smith
Journal:  J Med Virol       Date:  2007-04       Impact factor: 2.327

9.  Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes.

Authors:  H Bielefeldt-Ohmann
Journal:  Virus Res       Date:  1998-09       Impact factor: 3.303

10.  Characterization of a structural intermediate of flavivirus membrane fusion.

Authors:  Karin Stiasny; Christian Kössl; Jean Lepault; Félix A Rey; Franz X Heinz
Journal:  PLoS Pathog       Date:  2007-02       Impact factor: 6.823
View more
  47 in total

1.  Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 Å Resolution.

Authors:  Madhumati Sevvana; Feng Long; Andrew S Miller; Thomas Klose; Geeta Buda; Lei Sun; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2018-06-26       Impact factor: 5.006

Review 2.  Virus interactions with endothelial cell receptors: implications for viral pathogenesis.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Curr Opin Virol       Date:  2014-07-24       Impact factor: 7.090

3.  Mutational analysis of the zippering reaction during flavivirus membrane fusion.

Authors:  Karen Pangerl; Franz X Heinz; Karin Stiasny
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

4.  Productive dengue virus infection of human endothelial cells is directed by heparan sulfate-containing proteoglycan receptors.

Authors:  Nadine Dalrymple; Erich R Mackow
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 5.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

Review 6.  Mapping the diverse structural landscape of the flavivirus antibody repertoire.

Authors:  Madhumati Sevvana; Richard J Kuhn
Journal:  Curr Opin Virol       Date:  2020-08-13       Impact factor: 7.090

7.  Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.

Authors:  Stephen Tottey; Yoko Shoji; R Mark Jones; Jessica A Chichester; Brian J Green; Konstantin Musiychuk; Huaxin Si; Slobodanka D Manceva; Amy Rhee; Moneim Shamloul; Joey Norikane; Rosane C Guimarães; Elena Caride; Andrea N M R Silva; Marisol Simões; Patricia C C Neves; Renato Marchevsky; Marcos S Freire; Stephen J Streatfield; Vidadi Yusibov
Journal:  Am J Trop Med Hyg       Date:  2017-11-30       Impact factor: 2.345

Review 8.  Zika virus: An emerging flavivirus.

Authors:  Sang-Im Yun; Young-Min Lee
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

Review 9.  Protein Interactions during the Flavivirus and Hepacivirus Life Cycle.

Authors:  Gisa Gerold; Janina Bruening; Bettina Weigel; Thomas Pietschmann
Journal:  Mol Cell Proteomics       Date:  2017-01-11       Impact factor: 5.911

10.  A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.

Authors:  Amanda E Calvert; Kandice L Dixon; Joseph Piper; Susan L Bennett; Brett A Thibodeaux; Alan D T Barrett; John T Roehrig; Carol D Blair
Journal:  Antiviral Res       Date:  2016-04-26       Impact factor: 5.970
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.